Citation Impact
Citing Papers
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary
2014 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary
2014 Standout
Counteraction of the vasodilator effects of enalapril by aspirin in severe heart failure
1992
Should We STOP Angiotensin Converting Enzyme Inhibitors/Angiotensin Receptor Blockers in Advanced Kidney Disease?
2016 Standout
Calcium's Role in Mechanotransduction during Muscle Development
2014 Standout
Importance of hemodynamic response to therapy in predicting survival with ejection fraction ≤ 20% secondary to ischemic or nonischemic dilated cardiomyopathy
1990
Effect of Captopril on Mortality and Morbidity in Patients with Left Ventricular Dysfunction after Myocardial Infarction
1992 Standout
The right ventricle: anatomy, physiology, and clinical importance
1991
Ferric Carboxymaltose in Patients with Heart Failure and Iron Deficiency
2009 Standout
Percutaneous Repair or Surgery for Mitral Regurgitation
2011 Standout
Exercise Standards for Testing and Training
2013 Standout
Elevated Circulating Levels of Tumor Necrosis Factor in Severe Chronic Heart Failure
1990 Standout
Retrieval and analysis of particulate debris after saphenous vein graft intervention
1999
Left ventricular response to submaximal and maximal exercise in asymptomatic aortic regurgitation
1988
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities
2008 Standout
Effect of Oral Milrinone on Mortality in Severe Chronic Heart Failure
1991 Standout
Effect of quinapril on blood pressure and heart rate in congestive heart failure
1992
Lisinopril in the Treatment of Congestive Heart Failure in Elderly Patients: Comparison versus Captopril
1997
Effect of direct vasodilation with hydralazine versus angiotensin-converting enzyme inhibition with captopril on mortality in advanced heart failure: The Hy-C trial
1992
Angiotensin‐converting enzyme inhibition and physical training in heart failure
1991
Trends in Heart Failure Incidence and Survival in a Community-Based Population
2004 Standout
Myocarditis
2011 Standout
Heart failure management: The impact of drug therapy on survival
1988
Prognostic Importance of Elevated Jugular Venous Pressure and a Third Heart Sound in Patients with Heart Failure
2001 Standout
Growth Differentiation Factor 11 Is a Circulating Factor that Reverses Age-Related Cardiac Hypertrophy
2013 Standout
Effects of Multisite Biventricular Pacing in Patients with Heart Failure and Intraventricular Conduction Delay
2001 Standout
A Comparison of Enalapril with Hydralazine–Isosorbide Dinitrate in the Treatment of Chronic Congestive Heart Failure
1991 Standout
Clinician’s Guide to Cardiopulmonary Exercise Testing in Adults
2010 Standout
Short- and long-acting angiotensin-converting enzyme inhibitors: A randomized trial of lisinopril versus captopril in the treatment of congestive heart failure
1989
Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE)
1997 Standout
Patterns of left ventricular dilation during the six months after myocardial infarction
1989
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
1999 Standout
Use of a Continuous-Flow Device in Patients Awaiting Heart Transplantation
2007 Standout
Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study
2001 Standout
Trends in Prevalence and Outcome of Heart Failure with Preserved Ejection Fraction
2006 Standout
Vasodilator and inotropic drugs for the treatment of chronic heart failure: Distinguishing hype from hope
1988
Comparison of ST segment depression in upright treadmill and supine bicycle exercise testing
1988
Late Cardiac Effects of Doxorubicin Therapy for Acute Lymphoblastic Leukemia in Childhood
1991 Standout
Chronic Aortic Insufficiency: Factors Associated with Progression to Aortic Valve Replacement
1989
Exercise limitation in chronic heart failure: Central role of the periphery
1996
The therapeutic potential of ischemic conditioning: an update
2011
Bias in meta-analysis detected by a simple, graphical test
1997 Standout
What is the ideal study design for evaluation of treatment for heart failure?: Insights from trials assessing the effect of ACE inhibitors on exercise capacity
1996
Myocarditis
2009 Standout
Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms
2010 Standout
ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult
2005 Standout
Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. Collaborative Group on ACE Inhibitor Trials.
1995
Functional Renal Insufficiency During Long-Term Therapy with Captopril and Enalapril in Severe Chronic Heart Failure
1987
Differences in generalist and specialist physicians’ knowledge and use of angiotensin-converting enzyme inhibitors for congestive heart failure
1997
ACC/AHA 2005 Practice Guidelines for the Management of Patients With Peripheral Arterial Disease (Lower Extremity, Renal, Mesenteric, and Abdominal Aortic)
2006 Standout
Long-term oral administration of amrinone for congestive heart failure: lack of efficacy in a multicenter controlled trial.
1985
Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications.
1990 Standout
AHA/ACC Guidelines for Secondary Prevention for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2006 Update
2006 Standout
Association between the exercise ejection fraction response and systolic wall stress in patients with chronic aortic insufficiency.
1985
Felodipine in patients with chronic heart failure: discrepant haemodynamic and clinical effects.
1987
Ejection fraction response to supine exercise in asymptomatic aortic regurgitation: Relation to simultaneous hemodynamic measurements
1985
Contrasting peripheral short-term and long-term effects of converting enzyme inhibition in patients with congestive heart failure. A double-blind, placebo-controlled trial.
1989
Effects of enalapril in heart failure: a double blind study of effects on exercise performance, renal function, hormones, and metabolic state.
1985
Efficacy and Safety of Exercise Training in Patients With Chronic Heart Failure
2009 Standout
2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy
2011 Standout
2009 Focused Update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009
Mitochondrial Reactive Oxygen Species (ROS) and ROS-Induced ROS Release
2014 Standout
ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease: Executive Summary
2008 Standout
Forecasting the Future of Cardiovascular Disease in the United States
2011 Standout
Survival after an experimental myocardial infarction: beneficial effects of long-term therapy with captopril.
1985
Plasma Norepinephrine as a Guide to Prognosis in Patients with Chronic Congestive Heart Failure
1984 Standout
Acute and long-term effects of enalapril on the cardiovascular response to exercise and exercise tolerance in patients with congestive heart failure
1985
ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2006 Standout
Contemporary Definitions and Classification of the Cardiomyopathies
2006 Standout
Effect of epinephrine and lidocaine therapy on outcome after cardiac arrest due to ventricular fibrillation.
1990
Evaluation of relationship between myocardial contractile state and left ventricular function in patients with aortic regurgitation.
1985
Comparative hemodynamic and clinical effects of long-term treatment with prazosin and captopril for severe chronic congestive heart failure secondary to coronary artery disease or idiopathic dilated cardiomyopathy
1986
Determinants of clinical response and survival in patients with congestive heart failure treated with captopril
1982
Oral amrinone for the treatment of chronic congestive heart failure: Results of a multicenter randomized double-blind and placebo-controlled withdrawal study
1984
Correlates and prognostic implication of exercise capacity in chronic congestive heart failure
1985
Comparison of Captopril and Enalapril in Patients with Severe Chronic Heart Failure
1986
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2020 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Cardiac βARK1 inhibition prolongs survival and augments β blocker therapy in a mouse model of severe heart failure
2001 StandoutNobel
Right Ventricular Function in Cardiovascular Disease, Part I
2008 Standout
Hemodynamic patterns of response during long-term captopril therapy for severe chronic heart failure.
1983
Relative Efficacy of Vasodilator Therapy in Chronic Congestive Heart Failure
1988
Infarct artery perfusion and changes in left ventricular volume in the month after acute myocardial infarction
1987
Early Detection of Anthracycline Cardiotoxicity and Improvement With Heart Failure Therapy
2015 Standout
Influence of chronic captopril therapy on the infarcted left ventricle of the rat.
1985
Heart Rate Variability
1996 Standout
Heart rate variability: Standards of measurement, physiological interpretation, and clinical use
1996 Standout
Hemodynamic and clinical limitations of long-term inotropic therapy with amrinone in patients with severe chronic heart failure.
1984
Skeletal muscle metabolism during exercise under ischemic conditions in congestive heart failure. Evidence for abnormalities unrelated to blood flow.
1988
Angiotensin Receptor Blockade and Exercise Capacity in Adults With Systemic Right Ventricles
2005
Part 8: Adult Advanced Cardiovascular Life Support
2010 Standout
Captopril in heart failure. A double blind controlled trial.
1984
Relation between serum sodium concentration and the hemodynamic and clinical responses to converting enzyme inhibition with captopril in severe heart failure
1984
Hemodynamic changes mimicking a vasodilator drug response in the absence of drug therapy after right heart catheterization in patients with chronic heart failure.
1985
Enalapril in patients with chronic heart failure: a placebo-controlled, randomized, double-blind study.
1984
Works of B Krämer being referenced
Acute and long-term effects of vasodilator therapy on resting and exercise hemodynamics and exercise tolerance.
1981
Controlled trial of captopril in chronic heart failure: a rest and exercise hemodynamic study.
1983
The effects of lidocaine on the ventricular fibrillation threshold and primary ventricular fibrillation following acute experimental coronary occlusion
1981
Postural hypotension and tachycardia during hydralazine--isosorbide dinitrate therapy for chronic heart failure.
1981
Acute and long‐term effects of captopril on exercise cardiac performance and exercise capacity in congestive heart failure.
1982
Hemodynamic and radionuclide effects of acute captopril therapy for heart failure: changes in left and right ventricular volumes and function at rest and during exercise.
1982
Hemodynamic differences between supine and upright exercise in patients with congestive heart failure.
1982
Lack of relationship between the short-term hemodynamic effects of captopril and subsequent clinical responses.
1984
Radionuclide measurement of left ventricular volume: comparison of geometric and counts-based methods.
1982
Optimal therapy for degenerated saphenous vein graft disease.
1995
Changes in ventricular fibrillation threshold during repeated short-term coronary occlusion and release
1977